UnitedHealth Group Incorporated $UNH Shares Sold by Fort Washington Investment Advisors Inc. OH

Key Points

• Fort Washington Investment Advisors Inc. OH reduced its stake in UnitedHealth Group by 13.7%, selling 72,384 shares and holding 457,719 shares at the end of the second quarter.
• UnitedHealth Group's stock price was down 0.4% at $344.15, with a market cap of $311.69 billion and a price-to-earnings ratio of 14.91.
• Equities analysts have mixed ratings for UnitedHealth Group, with a consensus rating of "Moderate Buy" and targets ranging from $325 to $440.

Fort Washington Investment Advisors Inc. OH lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 457,719 shares of the healthcare conglomerate's stock after selling 72,384 shares during the period. UnitedHealth Group comprises about 0.8% of Fort Washington Investment Advisors Inc. OH's holdings, making the stock its 27th largest position. Fort Washington Investment Advisors Inc. OH owned 0.05% of UnitedHealth Group worth $142,795,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Citizens National Bank Trust Department boosted its holdings in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares in the last quarter. Caitlin John LLC boosted its holdings in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after purchasing an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $1,324,000. Wealth Effects LLC boosted its holdings in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. Finally, Arlington Partners LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $2,229,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Cantor Fitzgerald restated an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Barclays boosted their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Finally, Truist Financial upped their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Stock Down 0.4%

Shares of UnitedHealth Group stock opened at $344.15 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a fifty day moving average price of $301.20 and a 200 day moving average price of $359.58. The stock has a market cap of $311.69 billion, a price-to-earnings ratio of 14.91, a price-to-earnings-growth ratio of 2.24 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.